Want to see IN:VENUSREM full AI Analyst Report?

Venus Remedies Limited (VENUSREM) Financial Statements

1 Followers

Venus Remedies Limited Financial Overview

Venus Remedies Limited's market cap is currently ₹21.25B. The company's EPS TTM is ₹86.91; its P/E ratio is 18.09; and it has a dividend yield of 0.63%. Venus Remedies Limited is scheduled to report earnings on July 20, 2026, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Income Statement
Total Revenue	₹ 7.70B	₹ 6.48B	₹ 5.91B	₹ 5.56B	₹ 5.99B
Gross Profit	₹ 2.68B	₹ 1.66B	₹ 2.18B	₹ 2.25B	₹ 2.00B
Operating Income	₹ 1.22B	₹ 410.30M	₹ 331.57M	₹ 273.20M	₹ 280.97M
EBITDA	₹ 1.60B	₹ 944.10M	₹ 711.80M	₹ 703.46M	₹ 701.40M
Net Income	₹ 1.03B	₹ 453.20M	₹ 284.91M	₹ 265.70M	₹ 407.24M
Balance Sheet
Cash & Short-Term Investments	₹ 1.04B	₹ 1.64B	₹ 838.05M	₹ 720.77M	₹ 432.56M
Total Assets	₹ 8.54B	₹ 7.16B	₹ 6.27B	₹ 6.01B	₹ 5.80B
Total Debt	₹ 124.10M	₹ 16.90M	₹ 413.25M	₹ 422.90M	₹ 428.45M
Net Debt	₹ -182.00M	₹ -784.10M	₹ -76.30M	₹ 210.80M	₹ -4.11M
Total Liabilities	₹ 1.90B	₹ 1.55B	₹ 1.39B	₹ 1.41B	₹ 1.39B
Stockholders' Equity	₹ 6.64B	₹ 5.61B	₹ 4.88B	₹ 4.60B	₹ 4.40B
Cash Flow
Free Cash Flow	₹ 1.20B	₹ 812.90M	₹ 278.40M	₹ 288.02M	₹ 272.94M
Operating Cash Flow	₹ 1.57B	₹ 909.20M	₹ 372.85M	₹ 366.20M	₹ 410.01M
Investing Cash Flow	₹ -1.84B	₹ -807.90M	₹ -72.09M	₹ -508.30M	₹ -166.26M
Financing Cash Flow	₹ -25.30M	₹ -9.50M	₹ -10.83M	₹ -5.70M	₹ -94.77M

Currency in INR

Venus Remedies Limited Earnings and Revenue History

Income Statement >

Venus Remedies Limited Debt to Assets

Balance Sheet >

Venus Remedies Limited Cash Flow

Cash Flow >

Venus Remedies Limited Forecast EPS vs Actual EPS

Earnings >